4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0000950170-24-059506
Chief Executive Officer sold 5,000 shares at $13.22 ($66,093)
- Chief Executive Officer acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Townsend Richard Nolan · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-13 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,000 | $2.33 | $11,650 | 175,695 | D |
| 2024-05-13 | Sale : show line 2 in the form 10b5-1 | −5,000 | $13.22 | $66,093 | 170,695 | D |
| Open-market sales · 5,000 sh · avg $13.22 · $66,093 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-13 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −5,000 | $2.33 | $11,650 | 148,655 | D |
Loading xslF345X05/ownership.xml…